Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
The British Journal of Dermatology|January 1, 1992
Cancer family syndrome associated with multiple malignant melanomas and a malignant fibrous histiocytomaC Buckley, V Thomas, J Crow, et al.The British Journal of Dermatology|June 1, 1993
Neutrophilic eccrine hidradenitis with an unusual presentationL S Ostlere, J Wells, H P Stevens, et al.The British Journal of Dermatology|April 1, 1995
Efficacy of traditional Chinese herbal therapy in vitro. A model system for atopic eczema: inhibition of CD23 expression on blood monocytesY Latchman, G A Bungy, D J Atherton, et al.Journal of Cutaneous Pathology|June 1, 1996
p53 immunoreactivity in non-melanoma skin cancer from immunosuppressed and immunocompetent individuals: a comparative study of 246 tumoursS M Khorshid, M T Glover, L Churchill, et al.The Journal of Infection|March 1, 1986
The acute exanthem associated with seroconversion to human T-cell lymphotropic virus III in a homosexual manM H Rustin, C M Ridley, M D Smith, et al.The Journal of Investigative Dermatology|December 1, 1987
Serum from patients with Raynaud's phenomenon inhibits prostacyclin productionM H Rustin, H A Bull, S J Machin, et al.The British Journal of Dermatology|October 1, 1992
Phenytoin-induced pseudolymphoma. A report of a case and review of the literatureD W Harris, L Ostlere, C Buckley, et al.Clinical and Experimental Dermatology|September 1, 1989
Polyostotic fibrous dysplasia associated with extensive linear epidermal naeviM H Rustin, C B Bunker, J J Gilkes, et al.The British Journal of Dermatology|May 1, 1993
Pellagra secondary to 5-fluorouracilH P Stevens, L S Ostlere, R H Begent, et al.Angiology|December 1, 1985
CL115,347, an analogue of prostaglandin E2. Peripheral circulatory effects of single ascending doses administered transdermally in normal subjects and in patients with Raynaud's phenomenonE D Cooke, S A Bowcock, C J Watkins, et al.Pageof 8